These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11529776)

  • 1. Stereocontrolled synthesis of the northern part of potent proteasome inhibitor TMC-95A.
    Inoue M; Furuyama H; Sakazaki H; Hirama M
    Org Lett; 2001 Sep; 3(18):2863-5. PubMed ID: 11529776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A concise, total synthesis of the TMC-95A/B proteasome inhibitors.
    Albrecht BK; Williams RM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11949-54. PubMed ID: 15163792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The core structure of TMC-95A is a promising lead for reversible proteasome inhibition.
    Kaiser M; Groll M; Renner C; Huber R; Moroder L
    Angew Chem Int Ed Engl; 2002 Mar; 41(5):780-3. PubMed ID: 12491334
    [No Abstract]   [Full Text] [Related]  

  • 4. A concise formal total synthesis of TMC-95A/B proteasome inhibitors.
    Albrecht BK; Williams RM
    Org Lett; 2003 Jan; 5(2):197-200. PubMed ID: 12529139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The total synthesis of proteasome inhibitors TMC-95A and TMC-95B: discovery of a new method to generate cis-propenyl amides.
    Lin S; Danishefsky SJ
    Angew Chem Int Ed Engl; 2002 Feb; 41(3):512-5. PubMed ID: 12491396
    [No Abstract]   [Full Text] [Related]  

  • 6. TMC-95A, a reversible proteasome inhibitor, induces neurite outgrowth in PC12 cells.
    Inoue M; Zhai H; Sakazaki H; Furuyama H; Fukuyama Y; Hirama M
    Bioorg Med Chem Lett; 2004 Feb; 14(3):663-5. PubMed ID: 14741264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified synthetic TMC-95A/B analogues retain the potency of proteasome inhibitory activity.
    Yang ZQ; Kwok BH; Lin S; Koldobskiy MA; Crews CM; Danishefsky SJ
    Chembiochem; 2003 Jun; 4(6):508-13. PubMed ID: 12794861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities.
    Koguchi Y; Kohno J; Nishio M; Takahashi K; Okuda T; Ohnuki T; Komatsubara S
    J Antibiot (Tokyo); 2000 Feb; 53(2):105-9. PubMed ID: 10805568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a TMC-95A ketomethylene analogue by cyclization via intramolecular Suzuki coupling.
    Kaiser M; Siciliano C; Assfalg-Machleidt I; Groll M; Milbradt AG; Moroder L
    Org Lett; 2003 Sep; 5(19):3435-7. PubMed ID: 12967293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total synthesis of TMC-95A and -B via a new reaction leading to Z-enamides. Some preliminary findings as to SAR.
    Lin S; Yang ZQ; Kwok BH; Koldobskiy M; Crews CM; Danishefsky SJ
    J Am Chem Soc; 2004 May; 126(20):6347-55. PubMed ID: 15149232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome.
    Groll M; Götz M; Kaiser M; Weyher E; Moroder L
    Chem Biol; 2006 Jun; 13(6):607-14. PubMed ID: 16793518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093.
    Kohno J; Koguchi Y; Nishio M; Nakao K; Kuroda M; Shimizu R; Ohnuki T; Komatsubara S
    J Org Chem; 2000 Feb; 65(4):990-5. PubMed ID: 10814045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A convergent synthesis of the fully elaborated macrocyclic core of TMC-95A.
    Coste A; Bayle A; Marrot J; Evano G
    Org Lett; 2014 Mar; 16(5):1306-9. PubMed ID: 24559256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20S proteasome inhibition: designing noncovalent linear peptide mimics of the natural product TMC-95A.
    Groll M; Gallastegui N; Maréchal X; Le Ravalec V; Basse N; Richy N; Genin E; Huber R; Moroder L; Vidal J; Reboud-Ravaux M
    ChemMedChem; 2010 Oct; 5(10):1701-5. PubMed ID: 20715286
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor.
    Groll M; Koguchi Y; Huber R; Kohno J
    J Mol Biol; 2001 Aug; 311(3):543-8. PubMed ID: 11493007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short, stereocontrolled, and practical synthesis of alpha-methylomuralide, a potent inhibitor of proteasome function.
    Saravanan P; Corey EJ
    J Org Chem; 2003 Apr; 68(7):2760-4. PubMed ID: 12662049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMC-95A analogues with endocyclic biphenyl ether group as proteasome inhibitors.
    Kaiser M; Milbradt AG; Siciliano C; Assfalg-Machleidt I; Machleidt W; Groll M; Renner C; Moroder L
    Chem Biodivers; 2004 Jan; 1(1):161-73. PubMed ID: 17191784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity.
    Clerc J; Li N; Krahn D; Groll M; Bachmann AS; Florea BI; Overkleeft HS; Kaiser M
    Chem Commun (Camb); 2011 Jan; 47(1):385-7. PubMed ID: 20830349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitors.
    Maréchal X; Pujol A; Richy N; Genin E; Basse N; Reboud-Ravaux M; Vidal J
    Eur J Med Chem; 2012 Jun; 52():322-7. PubMed ID: 22440858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinyl ester-based cyclic peptide proteasome inhibitors.
    Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.